The purpose of this article is to review the data on LOH, also known as low T, and present the most recent evidence and recommendations regarding the approach to the patient from our case scenario. A 56-year-old overweight man with symptoms of low energy, daytime sleepiness, and decreased libido happens to be watching a golf tournament on TV from his favorite recliner and suddenly a commercial appears. Other studies found that the decline in testosterone with age might be more related to comorbidities that develop in many aging men. Because this study was carried out in one of the nation's largest commercially insured populations, these findings have a high degree of statistical power and are likely to be representative of other commercially insured populations across the U.S. In addition, men older than 50 years might have low testosterone levels with functional abnormalities at multiple levels of the hypothalamic-pituitary-testicular axis.1,2,3 Hypogonadism in male patients with testicular failure due to genetic disorders (eg, Klinefelter’s syndrome), orchitis, trauma, radiation, chemotherapy, or undescended testes, is known as hypergonadotropic hypogonadism or primary hypogonadism. In the postpubertal male, testosterone replacement therapy can be used to treat the signs and symptoms of low testosterone, which include loss of libido, erectile dysfunction, diminished intellectual capacity, depression, lethargy, osteoporosis, loss of muscle mass and strength, and some regression of secondary sexual characteristics. If luteinizing hormone and follicle-stimulating hormone levels are low (or inappropriately normal), secondary hypogonadism is diagnosed and hypothalamic/pituitary pathologies should be considered (11, 12) depending on the patient's presentation. However, patients receiving injections of testosterone enanthate or cypionate every 2 weeks will require an earlier measurement of serum testosterone at 1 to 2 weeks after commencement of therapy.3 In cases of primary and permanent secondary hypogonadism diagnosed in the prepubertal male, life long testosterone treatment is needed. If the total testosterone level is normal in the aging male presenting signs of hypogonadism, the clinician can measure free testosterone or measure SHBG and calculate bioavailable testosterone.9 To differentiate primary from secondary hypogonadism, early morning luteinizing hormone (LH) and follicle-stimulating hormone (FSH) levels must be obtained. Approximately 30% of the CDM population had at least one value in the laboratory database. Given the dramatic increase in testosterone prescribing during the last decade, understanding the extent to which screening and treatment practices are concordant with current clinical practice guidelines is critically important. The developer, David Dzeveckij, indicated that the app’s privacy practices may include handling of data as described below. Some men feel great with low-normal testosterone. Track your testosterone replacement therapy with confidence. You should also see a gynecologist before you start taking any birth control to see if there are any risks of side effects or complications from the changes that contraceptives cause in your hormones. Whether you're managing injections, gels, patches, or pellets, TRT Tracker provides everything you need to monitor your hormone health, maximize treatment outcomes, and experience the full benefits of optimized testosterone levels.THE ULTIMATE TRT COMPANIONTRT Tracker is specifically designed for men on Testosterone Replacement Therapy who want to optimize their protocol, track symptoms, monitor blood work, and improve communication with healthcare providers. A healthy male adult patient with a serum testosterone level greater than 400 ng/dL is unlikely to be testosterone deficient, and therefore clinical judgment should be exercised if he has symptoms suggestive of testosterone deficiency. In males, serum testosterone levels show a circadian variation, with the highest levels in the morning and lowest levels in the late afternoon. In addition, it is possible that, in some cases, physicians judge that symptoms (e.g., fatigue and loss of muscle mass) merit monitored testosterone therapy, even in the absence of clinically defined low testosterone levels. Men treated by endocrinologists and urologists were more likely to have been treated according to guideline recommendations than men treated by other specialties, including primary care. Among men who were tested, 19.5% did not meet Endocrine Society guidelines for low testosterone. TRT Tracker is the specialized solution designed specifically for testosterone optimization and management. Log doses, injections, labs and symptoms. Log doses, monitor symptoms, and share reports with your doctor. Sign up and start logging your labs and symptoms today. However, in community practice the choice of which testosterone parameter to measure is still debatable. Only free and weakly bound testosterone is bioavailable or able to bind to the androgen receptor.2,3 It has been reported that 12%, 19%, 28%, and 49% of men greater than 50, 60, 70, or 80 years of age, respectively, fit the criteria of hypogonadism.4 Hypogonadism can be of hypothalamic-pituitary origin or of testicular origin, or a combination of both, which is increasingly common in the aging male population.
